AstraZeneca and Lilly’s Alzheimer’s drug fails trial
The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial…
The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial…